PYC Therapeutics (ASX:PYC) has raised AU$133 million through its ongoing entitlement offer, part of a broader AU$146 million capital raise, according to a Wednesday filing with the Australian bourse.
The company expects to receive the remaining AU$13 million by April 30 after the underwriter for the outstanding balance has requested an extension citing liquidity issues, the filing said.
PYC is seeking payment guarantees and a bond from the underwriter to ensure the completion of the transaction, the filing added.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。